Skip to main content
Clinical Trials/IRCT2015011618389N3
IRCT2015011618389N3
Completed
Phase 3

A clinical trial of the comparison of the effect of drug Na/K citrate per os plus hydration with hydration alone on serum creatinine in high-risk patients after receiving contrast

Qom University of Medical Sciences and Health Services Vice chancellor0 sites400 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute renal failure.
Sponsor
Qom University of Medical Sciences and Health Services Vice chancellor
Enrollment
400
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Qom University of Medical Sciences and Health Services Vice chancellor

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria are the existence of at least one risk factor of contrast\-induced nephropathy, namely: 1\- Moderate systolic heart failure \[ (EF) Ejection Fraction between 30\-45%]2\- Diabetes mellitus 3\- Older than 75 year\-old 4\- Moderate renal insufficiency (serum creatinine level between 1/5\-2 mg/dl) 5\- Hypotension (systolic blood pressure less than 90 mm Hg 6\- Anaemia 7\- History of hypertension. Exclusion criteria; 1\- pregnancy and lactation 2\- History of allergic reaction to contrast media 3\- Occurrence of cardiogenic shock and pulmonary edema during study 4\-Urgent catheterization 5\- Serum creatinine level higher than 2 mg/dl and previous history of dialysis 6\- Receiving contrast medium 48 h before and after the intervention 7\- Receiving diuretics, N\-acetylcystein, sodium bicarbonate, theophylline, dopamine, mannitol, fenoldopam, metformin and NSAID’S during the study 8\- Requiring to continue hydration therapy (e.g., sepsis condition) 9\-Severe heart failure \[left ventricular ejection fraction (LVEF) less than 30%]

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials